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Some activities of EURADOS Working Group 9 (WG9) are presently funded by the European Commission (CONRAD
project). The objective of WG9 is to promote and co-ordinate research activities for the assessment of occupational exposures
to staff at workplaces in interventional radiology (IR) and nuclear medicine. For some of these applications, the skin of the
ﬁngers is the limiting organ for individual monitoring of external radiation. Therefore, sub-group 1 of WG9 deals with the
use of extremity dosemeters in medical radiation ﬁelds. The wide variety of radiation ﬁeld characteristics present in a medical
environment together with the difﬁculties in measuring a local dose that is representative for the maximum skin dose, usually
with one single detector, makes it difﬁcult to perform accurate extremity dosimetry. Sub-group 1 worked out a thorough litera-
ture review on extremity dosimetry issues in diagnostic and therapeutic nuclear medicine and positron emission tomography,
interventional radiology and interventional cardiology and brachytherapy. Some studies showed that the annual dose limits
could be exceeded if the required protection measures are not taken, especially in nuclear medicine. The continuous progress
in new applications and techniques requires an important effort in radiation protection and training.
INTRODUCTION
Monitoring of workers constitutes an integral part
of any radiological protection programme. In some
medical applications of radiation, there is a high risk
of locally high exposures because of direct handling
of sources, working close to radiation ﬁelds or the
use of beta-emitters. However, few measurements of
extremity doses have been reported in the literature,
especially compared with the large number of
workers worldwide who are exposed in the medical
ﬁeld. Medical practices are evolving fast, and new
techniques with ionising radiation come into play
very regularly, implying the need of radiation protec-
tion measures for medical staff and the implemen-
tation of new monitoring programmes.
Within the CONRAD project, a working group is
co-ordinating the research activities on occupational
exposures of medical staff. One of the tasks under-
taken was to perform an extensive literature
review on extremity dosimetry for radiation-exposed
medical staff. This paper describes the main ﬁndings
of this literature search. The paper is divided in
two main parts: one on interventional procedures,
and the other on nuclear medicine, and a third
shorter paragraph on brachytherapy.
The dose limits to be considered for workers are
the same for the extremities and for the skin, i.e.
500 mSv for 12 months averaged over 1 cm2 regard-
less of the area exposed. For the eye lens, the limit is
150 mSv per 12 months(1). If the dose to any part of
the extremities of a worker is likely to exceed three-
tenths of the annual dose limit, an additional dose-
meter should be worn on the part of the extremity
where the dose is expected to have its highest
value(1). However, the extremity monitoring may
impede the manipulations carried out by the staff.
Moreover, problems with the sterilisation and the
wearing of gloves are encountered. It should be
stressed out that no suitable dosemeters for knees,
feet or eye lenses are available at the present time.
USE OF EXTREMITY DOSEMETERS IN
INTERVENTIONAL PROCEDURES
In interventional radiology/cardiology (IR/IC),
X-rays are used to image catheters and guide wires
into position within the patient. These comprise both
diagnostic and lengthier interventional procedures,
where a number of conditions are treated using
stents or embolisation media. IR and IC procedures
require the operator and assisting personnel to remain
close to the patient, and thus to the primary radiation
beam. While the body area can be individually*Corresponding author: ﬁlip.vanhavere@sckcen.be
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shielded by protective lead aprons, the hands, legs
and the eye lenses remain practically unshielded. The
unsuitable use of protective tools or bad practice (e.g.
placing the hands in the direct X-ray beam) could
lead to high doses at unexpected positions.
The International Commission on Radiological
Protection (ICRP) Publication 85(2) has given
examples of the doses of the monitored workers for
various X-ray interventions. The dose ranges for
the same kind of procedures vary a lot, since there
are many factors affecting the extremity doses like
the protective devices, the X-ray geometry and
spectra, the irradiated area of the patient, etc.
Generally haemodynamic procedures, particularly
the percutane transluminal coronary angioplasty
(PTCA), involve high dose area product (DAP)
values due to intensive use of image acquisition and
therefore, the staff doses are higher than for other
procedures. The lowest doses for coronary angio-
graphies (CAs) were found in a hospital centre(3)
with very strict radiation protection policy (low
exposure rate ﬂuoroscopy modes, use of spectral
ﬁlters, low frame rate, proper use of protective
screens, protective collar, lead aprons and curtain
shields). The use of a protective barrier can reduce
staff doses by a factor of 2, whereas the use of a
ceiling mounted screen by a factor of 3(4).
For vascular radiology procedures, ﬁnger doses
up to 840 mSv per procedure(4) have been reported.
Without protective devices, the hand doses in angio-
graphies vary from 120 to 710 mSv per procedure. For
other interventional procedures (embolisation, stent
placements and vertebroplasty), following range of
hand doses are reported(6–9): 50–630 mSv per pro-
cedure. If lead protection is not used, the dose to the
feet may range from 320 to 2640 mSv per procedure,
which exceeds the hand exposure during the same
procedure(8). Studies(3,4,7,10) on IC procedures (CA,
PTCA and ablations) report shoulder doses between
10 and 100 mSv per procedure, feet doses between 10
and 200 mSv per procedure and hand doses between
260 and 350 mSv per procedure.
The doses to the legs in most of the biliary pro-
cedures are lower than the hand doses whether a
lead protection curtain is used or not. During stent-
ing, embolisation and angioplasty procedures, if no
shielding is used, the doses to the legs of the staff
are two to three times higher than the doses to the
hands. However, if a protective curtain is used, the
dose to the legs is reduced signiﬁcantly. The wide
range of staff doses at the extremities, even for the
same procedure or the same centre, emphasises the
importance of protective measures, staff experience
and protocols that are followed.
In many of the above studies, extrapolations of the
reported doses to the annual ones have been
attempted. Most studies estimate that the annual
extremity doses for hand, forehead and shoulders
stay below the limit. However, Vano et al.(4) reported
that the doses measured at the shoulder would be
higher than the limits. Damilakis et al.(5) also found
that operator hand-doses can approach the dose
limit during high workload.
The DAP value can be used as a radiological
workload tool, so it is often checked whether a
relationship between the DAP (as a measure for the
dose to the patient) and the staff extremity dose
exists. Although some studies found some good cor-
relation between staff doses and DAP values(3,8,11),
generally a wide range of radiation exposure relative
to patient dose is found(5,10,12). The bad correlation
can be explained by different parameters that affect
the extremity doses such as protective devices and
especially different protocols followed by the staff.
For instance, moving away from the table during
acquisition decreases the staff doses signiﬁcantly
while the DAP is unaffected. Therefore, it is not easy
to estimate staff doses from DAP values.
For interventional procedures, there are some
studies on the dose distribution across the hands in
order to ﬁnd the most suitable position for monitor-
ing(6,7,12). For most of the IR procedures, the bases
of the ring and little ﬁnger receive the highest dose,
and the type of procedure and the manipulations of
the staff affect the dose distribution. According to
Martin and Whitby(6), a ﬁnger dosemeter placed at
the little ﬁnger of each hand is appropriate for extre-
mity monitoring. However, during percutaneous pro-
cedures, the tips of ring and middle ﬁngers may
receive 20–30% higher doses(3).
EXTREMITY DOSIMETRY IN NUCLEAR
MEDICINE
Nuclear medicine is associated to all uses of
unsealed radioactive sources for therapy or diagnosis
purposes. Nuclear medicine is a matter of concern
as regards radiation protection of workers since,
ﬁrst, high radionuclide activities are needed, from
few tens to several thousands of megabecquerel,
secondly, the procedures require the handling of
radiopharmaceuticals at contact and/or very close
to the extremities (hands, ﬁngers) and, thirdly, often
pure beta-emitters and mixed photon/beta-emitters
are used.
Conventional diagnostic nuclear medicine
By conventional diagnostic nuclear medicine is
meant, any diagnosis procedure associated with a
scintigraphy carried out with gamma-cameras
(bones, heart, lungs, thyroid, etc.). The large
majority of these procedures use 99mTc, which rep-
resents 80–90%, the rest being mostly associated
with iodine, and to a lesser extend thallium (131I,
123I and 201Tl).
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Doses to hands and ﬁngers are generally reported
per gigabecquerel of activity handled. On the ﬁnger-
tip, doses between 0.007 and 0.18 mSv GBq21 were
measured. With ring dosemeters, values between
0.01 and 0.04 mSv GBq21 were found, and mean
hand doses between 0.017 and 0.18 mSv GBq21 are
given(12–19).
Harding et al.(13) assessed the protective value of
syringe shields for 99mTc. The study revealed that
although theoretical attenuation factors for commer-
cialised syringe shields are in the order of 100 for
99mTc, actual observed dose reductions were in the
order of 2 on average. This was attributed to the
design of the shields that does not protect in all
directions and to the fact that using these devices
slow down the process. Whitby and Martin(14)
found a 75–85% dose reduction by using a syringe
shield.
Hastings et al.(15) found that the choice of the
technique for checking the activity could lead to
dose reductions by more than a factor of 2. The
extremity doses can also differ largely between two
technicians according to their individual techniques
and expertise(12).
Martin and Whitby(6,14) found that the tip of the
index ﬁnger of the dominant hand is likely to be the
part that receives the maximum dose. The authors
also stated that this rule is not universally applicable
and depends on various individual circumstances,
e.g. on the way the syringe and vial are held. If a
ring dosemeter, for practical reasons, is worn at the
base of the ﬁnger, the dosemeter reading could be
ﬁve or six times smaller than the dose at the ﬁnger
tip. Vanhavere et al.(12) found values between 1.4
and 7.0 between the dose at the ring dosemeter pos-
ition and the maximum dose location. Jankowski
et al.(16) showed that the ﬁngertip dose can be nine
times larger than the ﬁnger nail dose. Stuardo(17)
studied four nuclear medicine technicians during
1 week performing dose preparation, administration
and imaging. At the tip of the index ﬁnger, a dose of
a factor 3 larger than the ring dose was found.
Different authors extrapolated the measured doses
to annual doses. Harding et al.(13) found that radio-
pharmacy and dispensing led to 330 mSv each, and
injections to 220 mSv annual doses. Chruscielewski
et al.(19) presented the results of measuring the
equivalent dose to the hands of 60 workers (physi-
cians, nurses, radiopharmacists and technicians)
during 7 months, representing several thousand
examinations. They estimated large variability in
annual doses. For example, the radiopharmacists of
one of the laboratories were associated with annual
hand doses ranging from 3.7 to 200 mSv, and all
workers of another laboratory revealed hand doses
ranging from 0.03 to 0.12 mSv only. Jankowski
et al.(16) reported a annual hand dose of 14.4–
87.6 mSv. Whitby and Martin(14) estimated annual
hand doses of 10–200 mSv and 5–40 mSv for radio-
pharmacy and nuclear medicine staff, respectively.
Positron emission tomography examinations
Positron emission tomography (PET) is considered
one of the most relevant diagnostic imaging tech-
niques to provide functional and quantitative
information for the organ of interest. The radiophar-
maceutical used in most of the cases is 18F-FDG.
The use of PET is increasing in most countries. PET
radiopharmaceuticals are positron emitters. One of
its features from a radiation protection point of view,
compared with 99mTc labelled radiopharmaceuticals,
is that they have higher speciﬁc gamma ray con-
stants, and larger half value layer (HVL).
Just as in conventional diagnostic nuclear medi-
cine, the occupational exposure of PET staff can
vary signiﬁcantly for different departments, workers
and practices. In the literature, there are few studies
dealing with the evaluation of occupational doses
for PET facilities(20–25). Chiesa et al.(26) reported on
radiation doses for PET technicians that were higher
than those received in conventional diagnostic
nuclear medicine departments. However, some more
recent studies(20,21) showed radiation doses for the
technicians similar to the doses received in conven-
tional diagnostic nuclear medicine departments.
These lower extremity doses may be explained by
the use of a homemade syringe drawing device, a
semiautomatic injector and patient video tracking,
allowing a shorter duration of contact between the
technician and the patient. Shielded syringes,
according to Biran et al.(22), can produce a 25%
reduction in the extremity dose. Doses of 0.16–
0.19 mSv GBq21 were reported(23) for the index and
the middle ﬁnger during the manipulation, while the
respective doses for the preparation of the radio-
pharmaceuticals are higher varying from 0.92 to
0.39 mSv GBq21. Tandon et al.(24) evaluated doses
at the ﬁngers during the dispensing, injection and
scintigraphy. The respective numbers for the above
phases are: 0.098, 0.324 and 0.56 mSv GBq21. The
5-y study of Marti-Climent and Pen˜uelas(25), in a
total of 7032 PET studies, showed ﬁnger doses for
nurses varying from 0.087 to 0.10 mSv GBq21, and
for technicians ranging from 0.16 to 0.54 mSv
GBq21. The study also revealed that special lead
containers and syringe manipulators can be efﬁcient
for reducing personal doses.
Some practical radiation protection measures
should be further analysed to reduce personal doses,
like interacting with the injected patient only when
required, and speeding up patient management.
Even the introduction of 3D PET scanning with
5- to 6-fold increase of sensitivity compared with the
2D, may reduce the dose to the personnel consider-
ably. This allows an important decrease of the
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activity injected to the patient with the consequent
reduction of workers’ exposure. A possible reduction
of dose to the hands of technicians can also be
achieved with a full automatic activity-dose
dispenser.
Nuclear medicine therapy
Unsealed radiation sources are being increasingly
used in nuclear medicine for radiation therapy, in
particular, nuclides that emit beta or mixed beta/
gamma radiation. Joint diseases are treated using
radiosynoviorthesis (RSO) by injecting 90Y, 186Re or
169Er solutions into the joints. Recently, radioimmuno-
therapy (RIT), using 90Y-labelled antibodies for
treating malign lymphoma, has been introduced in
clinical routines. Another promising method is the
peptide–receptor-guided radiotherapy (PRRT) for
neuroendocrinic tumours by means of 90Yor 177Lu.
Although the handling of radionuclides does not
essentially differ from diagnostic nuclear medicine,
in therapy, activities are much higher and very
often beta-emitters such as 90Y (Emax ¼ 2.28 MeV)
are used, thus producing a considerably higher dose/-
dose rate per activity unit than gamma-radionuclides.
The preparation and administration of radiophar-
maceuticals in RIT and PRRT requires the mani-
pulation of high activities of 90Y. In cases where
radiation protection measures are not properly kept,
even non-stochastic radiation damage may occur as
it was reported by Tosi(27).
In a recent paper(28), the authors studied extremity
exposure during the preparation and application of
90Y-labelled antibodies (Zevalinw) and peptides
(DOTA-TOCw). When using radiation protection
means (polymethylmethacrylate-shielding (PMMA)-
shielding, tongs, X-ray gloves), a mean dose at the
ﬁnger tips during labelling of 0.6–2.9 mSv per
patient was found. Depending on personal skill and
experience, the individual exposures comprised a
wide range of doses with a maximum of 30–40 mSv
during a single procedure. In France, ﬁnger doses up
to 20 mSv per patient were reported(29). In
Germany, the introduction of 90Y-Zevalinw therapy
into clinical routines was accompanied by extremity
dose measurements with thermoluminescent detec-
tors (TLD)(30,31). When the personnel worked under
an acceptable safety standard, the dose range
was 1.3–8.1 mSv GBq21 for the staff in charge of
labelling, and 0.3–2.2 mSv GBq21 for the doctors.
In a few cases, fundamental safety measures
were neglected, and local skin doses up to 600 mSv
(labelling) and 27 mSv (injection) were measured.
The authors stress the need of an adequate radiation
protection standard. As far as shielding is con-
cerned, it was also observed that tungsten syringe
shields provide a better protection for 90Y than
PMMA ones(29,32,33), in contradiction to the
recommendation made in ref.(34). Additionally,
routine monitoring with ring dosemeters is needed.
It is essential to use dosemeters that are appropriate
for measuring beta radiation. In theory, these dose-
meters should be worn close to the tips of the fore-
ﬁnger or thumb of the highly exposed hand.
In Germany, over 60 000 RSO therapies are per-
formed annually(35,36). All these studies revealed that
even with RSO, the highest dose is to be expected
on the top of the left foreﬁnger or thumb. This
happens when using these ﬁngers to maintain the
position of the needle of a syringe during with-
drawal, dispensing or injection of the radionuclide
solution. When safety standards are ignored, up to
200 mSv per day were estimated in single cases. It
was found that a ring dosemeter underestimates the
maximum skin dose by a factor of 3 on average
when the therapy is performed at a high level of
safety.
BRACHYTHERAPY
Brachytherapy treatment consists of the direct inser-
tion of radioactive sources, usually sealed sources,
into the target tissue. In the early days, the handling
of radioactive material was manual, thus implying a
potential high risk for the hand dose. However,
nowadays, most of the procedures are performed
using manual or remote afterloading machines, thus
reducing the personnel dose. The use of remote
afterloading devices is highly recommended to
reduce radiation exposure of medical staff and to
improve patient treatment.
In manual brachytherapy, the hands of staff
receive the higher doses during source preparation
or source implant in the patient. However, there are
very few published data. Ennow(37) investigated
ﬁnger doses for 192Ir and 137Cs manual implants.
His results showed an average monthly ﬁnger dose
of 1.5 mSv within a range of 0–43 mSv. For most of
the staff, the received dose is below the limits, but in
some cases high doses can be found. Along the
same lines, Huerga et al.(38) also claimed very low
ﬁnger doses in the handling of 125I seeds and 106Ru.
CONCLUSIONS
It is very difﬁcult to compare extremity doses in IR
unless comparable protective measures, procedures
and characteristics of X-ray equipment are used.
Even so, the differences from one operator to
another, and from one patient to another, can be
substantial. When good practice is used and protec-
tive measures are present, the occupational limits
should not be reached. However, it is very difﬁcult
to completely avoid accidental exposures such as
being exposed to the direct radiation beam. Besides,
the increase in complexity and the duration of the
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procedures give rise to higher patient and staff doses.
Depending on the set-up and the shielding protec-
tions, the limiting organs may very well be the eye
lens, the feet or the legs. Training and experience of
the staff play as well a very important role to radi-
ation protection issues. The use of protective devices,
such as lead aprons, collars, glasses, etc. can reduce
the dose to the staff. However, there are cases where
their use can impede a proper and quick operation.
Factors that should be avoided are the use of lateral
X-ray beams, the use of magniﬁcation factors or
anything that may interfere or lengthen the medical
procedure. Poor or even bad correlation has been
found between the extremity doses and the DAP
values in most of the cases mentioned in the litera-
ture review. It would be advisable to organise a
systematic programme of measurements and moni-
toring that could reveal in a better way the effect of
the implicated protection measures.
There is a consensus in the literature regarding the
requirement of regular extremity dose monitoring of
the staff in nuclear medicine. The wearing of appro-
priate extremity dosemeters should be a must for all
staff who directly handle radioactive sources or are
close to the patients. Nearly all authors point out
that generally the skin of the hands of workers in
nuclear medicine is primarily exposed, with a dis-
tinct variation in the dose across the hands.
Some studies showed that the annual dose limit of
500 mSv could be exceeded if the required optimis-
ation is not applied.
According to the literature, technicians working in
PET facilities usually receive slightly higher doses
than those working in conventional diagnostic
nuclear medicine departments. However, these doses
are generally below the limits if adequate radiation
protection measures are taken. It is important to
keep in mind that the maximum skin dose can occur
on the ﬁnger tips, and this can be considerably
higher than the dose measured with a ring dose-
meter. However, since dosemeters worn on the ﬁnger
tips can alter the touch sensation and in general are
not easily accepted by exposed workers, the ring
dosemeter value must be multiplied with a correc-
tion factor to ensure that the dose limit for the skin
is not exceeded.
The discrepancies between the reported doses in
various centres could be explained on the basis of
technological, instrumental and shielding variability.
The use of some radiation protection measures, such
as shielded syringes, monodose vials or automatic
injectors, can result in signiﬁcant dose reductions.
Still, during dispensing of the radiopharmaceuticals,
the use of a shield can be impractical and hampers
when an accurate volume and corresponding activity
has to be drawn. The continuous progress in new
applications and techniques requires an important
effort in both training and understanding of the new
techniques. Staff radiation protection is an import-
ant issue that cannot be ignored. Many of the refer-
enced papers show the need to be aware of the basic
radiation protection parameters to reduce external
dose: shielding, distance and time.
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